BECTON DICKINSON & CO — Director's Dealing 2020

Jul 16, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BECTON DICKINSON & CO (BDX)
CIK: 0000010795
Period of Report: 2020-07-14

Reporting Person: Kaltenbach Patrick (EVP & Pres Life Sciences)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-07-14	Rights to Common Stock Under BD Deferred Compensation Plan	$	A	620	Acquired		Common Stock (620)	Direct

Footnotes

F1: The securities convert to common stock on a one-for-one basis.

F2: The securities are distributed following termination of the reporting person's servicer, or on the date or dates specified by the reporting person.